GUIDANCE DOCUMENT
Translation of Good Laboratory Practice Study Reports: Questions and Answers November 2023
Not for implementation. Contains non-binding recommendations.
- Docket Number:
- FDA-2023-D-4719
- Issued by:
-
Guidance Issuing OfficeCenter for Drug Evaluation and Research
This FDA guidance provides information to sponsors and nonclinical laboratories regarding the language translation of study reports for studies conducted in compliance with good laboratory practice (GLP) regulations (21 CFR part 58) submitted to FDA for review.
Additional Guidance Resources
- Translation of Good Laboratory Practice Study Reports - Guidance Snapshot
- Translation of Good Laboratory Practice Study Reports - Podcast
- Translation of Good Laboratory Practice Study Reports - Podcast Transcript
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2023-D-4719.